Watermark
  Back to Search Results

BGB-A317-315

Active, not recruiting

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-315

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04379635

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20200821

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents